Catalyst Wire Dossier Catalyst Wire Dossier

Bivalent Inactivated Enterovirus Vaccine (Vero Cell)

enterovirus vaccine, inactivated, bivalent (Vero cell-derived) · Sinovac Biotech Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bivalent Inactivated Enterovirus Vaccine (Vero Cell), covering 2025-01-01 to 2025-01-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell) [Phase 3]

See pricing